Excision BioTherapeutics' Seed VC Round

Excision BioTherapeutics raised a round of funding on September 06, 2017. Investors include Artis Ventures.

Excision BioTherapeutics is developing gene-editing technology designed to treat and remove a large, essential DNA fragment from HIV.…

Articles about Excision BioTherapeutics' Seed VC Round: